| GILD |
Gilead Sciences, Inc. |
130.26B |
8.72% |
|
|
|
|
|
104.49 |
-1.92% |
38.50% |
61.83% |
|---|
| AMGN |
Amgen Inc. |
153.90B |
7.97% |
|
|
|
|
|
286.25 |
-1.61% |
41.20% |
56.98% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
62.74B |
7.63% |
|
|
|
|
|
586.66 |
-2.02% |
49.81% |
76.60% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
128.82B |
7.49% |
|
|
|
|
|
501.09 |
-1.65% |
36.44% |
50.15% |
|---|
| AZN |
AstraZeneca PLC |
433.37B |
3.83% |
|
|
|
|
|
69.89 |
-2.65% |
34.59% |
53.90% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
33.40B |
3.04% |
|
|
|
|
|
256.79 |
-2.45% |
41.52% |
36.77% |
|---|
| BIIB |
Biogen Inc. |
18.03B |
2.19% |
|
|
|
|
|
123.18 |
1.73% |
46.34% |
53.16% |
|---|
| ILMN |
Illumina, Inc. |
12.25B |
2.13% |
|
|
|
|
|
77.38 |
-0.28% |
63.17% |
71.43% |
|---|
| ARGX |
argenx SE |
38.75B |
2.00% |
|
|
|
|
|
634.60 |
-1.63% |
31.77% |
32.51% |
|---|
| UTHR |
United Therapeutics Corporation |
13.43B |
1.59% |
|
|
|
|
|
298.99 |
-1.35% |
35.09% |
74.12% |
|---|
| MRNA |
Moderna, Inc. |
10.38B |
1.53% |
|
|
|
|
|
26.91 |
-5.71% |
88.47% |
66.72% |
|---|
| VTRS |
Viatris Inc. |
10.21B |
1.48% |
|
|
|
|
|
8.55 |
1.54% |
30.87% |
74.08% |
|---|
| SNY |
Sanofi |
133.09B |
1.46% |
|
|
|
|
|
54.50 |
-0.83% |
31.16% |
51.59% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
10.63B |
1.40% |
|
|
|
|
|
107.42 |
-0.25% |
34.71% |
54.96% |
|---|
| SMMT |
Summit Therapeutics Inc. |
17.53B |
1.33% |
|
|
|
|
|
23.76 |
-1.49% |
115.05% |
26.81% |
|---|
| INCY |
Incyte Corporation |
11.98B |
1.32% |
|
|
|
|
|
61.89 |
-1.23% |
42.37% |
60.45% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.06B |
1.26% |
|
|
|
|
|
62.88 |
-1.27% |
33.04% |
54.68% |
|---|
| INSM |
Insmed Incorporated |
13.08B |
1.24% |
|
|
|
|
|
71.94 |
-0.08% |
46.27% |
15.34% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
6.11B |
1.15% |
|
|
|
|
|
62.16 |
-0.39% |
72.06% |
35.85% |
|---|
| RPRX |
Royalty Pharma plc |
14.05B |
1.13% |
|
|
|
|
|
32.42 |
-1.23% |
31.94% |
48.25% |
|---|
| BNTX |
BioNTech SE |
24.17B |
1.11% |
|
|
|
|
|
100.55 |
-3.46% |
45.15% |
64.02% |
|---|
| MEDP |
Medpace Holdings, Inc. |
8.70B |
1.05% |
|
|
|
|
|
302.82 |
-1.81% |
56.20% |
37.89% |
|---|
| PCVX |
Vaxcyte, Inc. |
4.36B |
1.00% |
|
|
|
|
|
33.87 |
-5.49% |
62.20% |
37.56% |
|---|
| EXEL |
Exelixis, Inc. |
10.68B |
0.96% |
|
|
|
|
|
38.74 |
-1.05% |
35.76% |
41.53% |
|---|
| ITCI |
Intra-Cellular Therapies Inc |
|
0.89% |
|
|
|
|
|
|
|
|
|
|---|
| ROIV |
Roivant Sciences Ltd. |
8.29B |
0.85% |
|
|
|
|
|
11.62 |
-0.04% |
32.36% |
56.10% |
|---|
| ASND |
Ascendis Pharma A/S |
10.21B |
0.82% |
|
|
|
|
|
170.60 |
0.09% |
44.73% |
29.99% |
|---|
| BGNE |
BeiGene Ltd ADR |
|
0.80% |
|
|
|
|
|
|
|
|
|
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.13B |
0.75% |
|
|
|
|
|
115.73 |
-1.05% |
31.17% |
65.04% |
|---|
| RVMD |
Revolution Medicines, Inc. |
7.43B |
0.74% |
|
|
|
|
|
39.95 |
-1.06% |
66.81% |
37.03% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
7.23B |
0.68% |
|
|
|
|
|
327.53 |
-1.91% |
61.15% |
65.88% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.49B |
0.61% |
|
|
|
|
|
60.65 |
-1.25% |
37.56% |
42.67% |
|---|
| BPMC |
Blueprint Medicines Corporation |
6.24B |
0.56% |
|
|
|
|
|
96.69 |
8.03% |
66.68% |
54.00% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.02B |
0.56% |
|
|
|
|
|
31.56 |
2.77% |
57.02% |
61.42% |
|---|
| CYTK |
Cytokinetics, Incorporated |
5.10B |
0.55% |
|
|
|
|
|
42.78 |
-0.15% |
54.27% |
55.41% |
|---|
| TEM |
Tempus AI Inc |
|
0.53% |
|
|
|
|
|
|
|
|
|
|---|
| BBIO |
BridgeBio Pharma, Inc. |
7.05B |
0.53% |
|
|
|
|
|
37.12 |
-3.23% |
60.00% |
27.42% |
|---|
| NUVL |
Nuvalent, Inc. |
5.48B |
0.52% |
|
|
|
|
|
76.57 |
-0.23% |
47.10% |
53.54% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
3.07B |
0.48% |
|
|
|
|
|
32.78 |
-1.83% |
70.01% |
18.21% |
|---|
| ALKS |
Alkermes plc |
4.95B |
0.47% |
|
|
|
|
|
30.00 |
4.28% |
55.46% |
121.60% |
|---|
| KRYS |
Krystal Biotech, Inc. |
4.80B |
0.45% |
|
|
|
|
|
165.98 |
-2.30% |
46.99% |
66.81% |
|---|
| ACLX |
Arcellx, Inc. |
3.54B |
0.42% |
|
|
|
|
|
64.35 |
-0.92% |
46.12% |
64.83% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
5.42B |
0.42% |
|
|
|
|
|
111.18 |
-0.99% |
49.12% |
29.52% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
3.08B |
0.41% |
|
|
|
|
|
32.49 |
-1.28% |
62.30% |
28.21% |
|---|
| ADMA |
ADMA Biologics, Inc. |
5.58B |
0.41% |
|
|
|
|
|
23.38 |
-1.76% |
61.47% |
32.66% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
2.39B |
0.40% |
|
|
|
|
|
19.03 |
-0.94% |
43.44% |
69.35% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
3.62B |
0.40% |
|
|
|
|
|
38.56 |
-1.08% |
71.90% |
57.54% |
|---|
| GH |
Guardant Health, Inc. |
5.99B |
0.37% |
|
|
|
|
|
48.50 |
2.68% |
66.47% |
63.57% |
|---|
| IMVT |
Immunovant, Inc. |
2.71B |
0.36% |
|
|
|
|
|
15.97 |
-1.11% |
77.80% |
35.68% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.85B |
0.36% |
|
|
|
|
|
31.99 |
-2.02% |
67.15% |
60.34% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
3.88B |
0.35% |
|
|
|
|
|
49.23 |
-1.22% |
48.14% |
95.97% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.30B |
0.34% |
|
|
|
|
|
38.23 |
-1.14% |
66.84% |
64.32% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
4.06B |
0.34% |
|
|
|
|
|
63.93 |
-1.93% |
54.39% |
39.04% |
|---|
| VRNA |
Verona Pharma plc |
6.09B |
0.34% |
|
|
|
|
|
71.68 |
-0.54% |
57.13% |
29.37% |
|---|
| ALVO |
Alvotech |
2.38B |
0.34% |
|
|
|
|
|
7.89 |
0.70% |
N/A |
N/A |
|---|
| NVCR |
NovoCure Limited |
2.00B |
0.33% |
|
|
|
|
|
17.95 |
-1.07% |
49.92% |
51.12% |
|---|
| VCYT |
Veracyte, Inc. |
2.36B |
0.31% |
|
|
|
|
|
30.28 |
-0.72% |
62.23% |
55.17% |
|---|
| DNLI |
Denali Therapeutics Inc. |
2.31B |
0.29% |
|
|
|
|
|
15.92 |
-4.38% |
64.25% |
57.34% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
2.89B |
0.29% |
|
|
|
|
|
37.79 |
-1.09% |
55.26% |
44.91% |
|---|
| MRUS |
Merus N.V. |
3.15B |
0.29% |
|
|
|
|
|
45.51 |
0.26% |
47.93% |
43.51% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
2.13B |
0.29% |
|
|
|
|
|
6.93 |
-9.77% |
51.71% |
52.97% |
|---|
| TWST |
Twist Bioscience Corporation |
2.26B |
0.28% |
|
|
|
|
|
37.82 |
-1.30% |
66.71% |
52.92% |
|---|
| JANX |
Janux Therapeutics, Inc. |
1.91B |
0.28% |
|
|
|
|
|
32.31 |
-2.68% |
81.13% |
30.50% |
|---|
| VCEL |
Vericel Corporation |
1.91B |
0.28% |
|
|
|
|
|
38.06 |
0.09% |
58.27% |
85.41% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.41B |
0.28% |
|
|
|
|
|
14.45 |
-1.06% |
52.38% |
77.59% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.18B |
0.28% |
|
|
|
|
|
5.52 |
-1.34% |
92.26% |
43.70% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
1.71B |
0.27% |
|
|
|
|
|
16.26 |
-0.88% |
89.13% |
12.77% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
3.47B |
0.27% |
|
|
|
|
|
46.26 |
-0.09% |
102.18% |
55.95% |
|---|
| LEGN |
Legend Biotech Corporation |
3.17B |
0.26% |
|
|
|
|
|
34.47 |
-1.37% |
65.05% |
22.04% |
|---|
| VERA |
Vera Therapeutics, Inc. |
1.47B |
0.26% |
|
|
|
|
|
23.13 |
-1.05% |
65.71% |
88.52% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
2.18B |
0.26% |
|
|
|
|
|
33.61 |
-1.93% |
67.60% |
68.87% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.55B |
0.24% |
|
|
|
|
|
7.64 |
-0.33% |
67.35% |
79.44% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
1.33B |
0.24% |
|
|
|
|
|
11.73 |
-0.51% |
230.48% |
34.93% |
|---|
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.15B |
0.24% |
|
|
|
|
|
19.58 |
2.33% |
113.43% |
32.08% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
1.89B |
0.23% |
|
|
|
|
|
13.78 |
-0.83% |
56.04% |
33.68% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.75B |
0.23% |
|
|
|
|
|
44.85 |
-2.12% |
68.70% |
22.08% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
1.12B |
0.22% |
|
|
|
|
|
3.42 |
-4.87% |
130.38% |
48.84% |
|---|
| BEAM |
Beam Therapeutics Inc. |
1.99B |
0.22% |
|
|
|
|
|
19.75 |
-0.90% |
63.92% |
49.12% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
1.74B |
0.22% |
|
|
|
|
|
19.87 |
-1.32% |
142.62% |
46.95% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
2.13B |
0.21% |
|
|
|
|
|
51.25 |
-1.28% |
72.63% |
25.46% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
2.11B |
0.21% |
|
|
|
|
|
109.41 |
-0.41% |
51.23% |
67.38% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
2.34B |
0.20% |
|
|
|
|
|
39.37 |
0.31% |
66.75% |
66.98% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
1.78B |
0.20% |
|
|
|
|
|
31.89 |
-1.82% |
43.71% |
39.14% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
2.07B |
0.20% |
|
|
|
|
|
27.21 |
0.98% |
102.73% |
71.29% |
|---|
| GERN |
Geron Corporation |
863.02M |
0.20% |
|
|
|
|
|
1.3550 |
-3.90% |
92.88% |
46.31% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
2.11B |
0.20% |
|
|
|
|
|
42.62 |
-1.92% |
49.91% |
40.08% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
3.56B |
0.20% |
|
|
|
|
|
44.69 |
-2.03% |
73.43% |
13.69% |
|---|
| WVE |
Wave Life Sciences Ltd. |
1.16B |
0.20% |
|
|
|
|
|
7.56 |
-2.07% |
317.00% |
35.96% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
1.68B |
0.19% |
|
|
|
|
|
29.19 |
-0.95% |
54.28% |
68.91% |
|---|
| IBRX |
ImmunityBio, Inc. |
2.16B |
0.19% |
|
|
|
|
|
2.4450 |
-2.59% |
162.94% |
80.02% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
1.69B |
0.19% |
|
|
|
|
|
29.21 |
-1.63% |
67.83% |
50.52% |
|---|
| IRON |
Disc Medicine, Inc. |
1.66B |
0.19% |
|
|
|
|
|
47.91 |
-3.06% |
76.09% |
50.44% |
|---|
| MNKD |
MannKind Corporation |
1.48B |
0.19% |
|
|
|
|
|
4.88 |
-3.27% |
234.87% |
55.39% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
119.69M |
0.18% |
|
|
|
|
|
0.7400 |
-5.10% |
105.51% |
50.00% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
1.15B |
0.18% |
|
|
|
|
|
24.19 |
-0.90% |
55.34% |
75.57% |
|---|
| FTRE |
Fortrea Holdings Inc. |
557.44M |
0.17% |
|
|
|
|
|
6.18 |
-0.80% |
63.01% |
76.00% |
|---|
| GPCR |
Structure Therapeutics Inc. |
514.34M |
0.17% |
|
|
|
|
|
26.94 |
-0.24% |
82.10% |
16.95% |
|---|
| DVAX |
Dynavax Technologies Corporation |
1.41B |
0.17% |
|
|
|
|
|
11.49 |
-2.26% |
247.79% |
33.59% |
|---|
| INDV |
Indivior PLC |
1.47B |
0.17% |
|
|
|
|
|
11.78 |
2.35% |
108.09% |
75.84% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
1.71B |
0.17% |
|
|
|
|
|
14.38 |
-3.52% |
80.40% |
50.78% |
|---|